Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
N4 Pharma PLC (GB:N4P)
LSE:N4P
N4 Pharma (N4P) Share Price & Analysis
1 Followers
N4P Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range0.60p - 2.29p
Previous Close0.85p
Volume649.20K
Average Volume (3M)690.24K
Market Cap
£8.16M
Enterprise Value6.24M
Total Cash (Recent Filing)£1.92M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)-2.3
Beta0.18
Next Earnings
Sep 19, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding181,080,349
10 Day Avg. Volume2,128,462
30 Day Avg. Volume690,236
Standard Deviation0.38
R-Squared0.03
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)1.03
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
N4 Pharma News
PremiumCompany Announcements
N4 Pharma Announces Annual Report and AGM
PremiumCompany Announcements
N4 Pharma Reveals SRI Collaboration Webinar
PremiumCompany Announcements
N4 Pharma Partners with SRI to Innovate Biomedicine
PremiumCompany Announcements
N4 Pharma Optimistic Despite 2023 LossesOptions Prices
Currently, No data available
---
Ownership Overview
47.17%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
52.83% Public Companies and
Individual Investors
N4P FAQ
What was N4 Pharma PLC’s price range in the past 12 months?
N4 Pharma PLC lowest share price was 0.60p and its highest was 2.29p in the past 12 months.
What is N4 Pharma PLC’s market cap?
Currently, no data Available
When is N4 Pharma PLC’s upcoming earnings report date?
N4 Pharma PLC’s upcoming earnings report date is Sep 19, 2024 which is in 138 days.
How were N4 Pharma PLC’s earnings last quarter?
Currently, no data Available
Is N4 Pharma PLC overvalued?
According to Wall Street analysts N4 Pharma PLC’s price is currently Overvalued.
Does N4 Pharma PLC pay dividends?
N4 Pharma PLC does not currently pay dividends.
What is N4 Pharma PLC’s EPS estimate?
N4 Pharma PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does N4 Pharma PLC have?
N4 Pharma PLC has 268,780,330 shares outstanding.
What happened to N4 Pharma PLC’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of N4 Pharma PLC?
Currently, no hedge funds are holding shares in GB:N4P
---
N4 Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
N4 Pharma PLC
N4 Pharma PLC is a United Kingdom-based specialist pharmaceutical company. The company is engaged in reformulating existing drugs and vaccines to improve their performance to benefit the patients. The group operates in one business segment, that of the development and commercialization of medicines via its delivery system called Nuvec.
---
Technical Analysis
C4X Discovery Holdings
―
ImmuPharma
―
Oxford Cannabinoid Technologies Holdings
―
Akanda Corp
―
---